Patent Assignment
Reel/Frame 018636/0013
Assignment of Assignor's Interest
Recorded: 2006-12-14
Pages: 9
Assignor
AVENTIS PHARMA S.A.
Executed: 2006-12-06
Assignee
PFIZER INC.
235 EAST 42ND STREET, NEW YORK, NEW YORK, 10017
Covered Properties
(17)
Method for Treating Cancer Using Camptothecin Derivatives and 5-Fluorouracil
Patent:
6,403,569 →
Application:
09/559,737 →
Preparation of Camptothecin and Nothapodytine Derivatives
Patent:
6,500,953 →
Application:
09/744,547 →
Use of Camptothecin Derivatives, with Reduced Gastrointestinal Toxicity
Patent:
6,476,043 →
Application:
09/762,092 →
Composition Comprising Camptothecin and a Pyrimidine Derivative for the Treatment of Cancer
Composition Comprising Camptothecin or a Camptothecin Derivative and an Alkylating Agent for the Treatment of Cancer
Composition comprising camptothecin or a camptothecin derivative and a topoisomerase II inhibitor for the treatment of cancer
Application:
09/809,329 →
Publication:
US 2003/0195161
Preparation of Camptothecin and of Its Derivatives
Combination Comprising Camptothecin and a Stilbene Derivative for the Treatment of Cancer
Composition and Method Comprising Cpt-11 and a Pyrimidine Derivative for the Treatment of Cancer
Method for Treating Cancer Using Camptothecin Derivatives and 5-Fluorouracil
Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
Application:
10/245,500 →
Publication:
US 2003/0096789
Method for Treating Cancer Using Camptothecin Derivatives and 5-Fluorouracil
Application:
10/875,019 →
Publication:
US 2004/0229841
Method for Treating Cancer Using Camptothecin Derivatives and 5-Fluorouracil
Application:
60/131,678 →
Oral composition comprising capecitabine and camptothecine for the treatment of cancer
Application:
60/185,378 →
Composition comprising camptothecin and cyclophosphamide for the treatment of cancer
Application:
60/190,007 →
Composition comprising camptothecin and doxorubicin for the treatment cancer
Application:
60/190,061 →
Composition comprising camptothecin and a pyrimidine derivaative for the treatment of cancer
Application:
60/208,938 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 26, 1999
From: ACHERRATH, WOLF R.
To: RHONE-POULENC RORER S.A.
Reel/Frame 010199/0314 →
Assignment of Assignor's Interest
Dec 20, 2000
From: ACHTERRATH, WOLF R.
To: AVENTIS PHARMA S.A.
Reel/Frame 011376/0273 →
Assignment of Assignor's Interest
Jan 26, 2001
From: MEKOUAR, KHALID; GENISSON, YVES; LEUE, STEFANIE; GREENE, ANDREW-ELLIOTT
To: AVENTIS PHARMA S.A.
Reel/Frame 011563/0626 →
Change of Name
Feb 28, 2001
From: RHONE-POULENC RORER S.A.
To: AVENTIS PHARMA S.A.
Reel/Frame 011566/0692 →
Assignment of Assignor's Interest
Mar 7, 2001
From: BISSERY, MARIE-CHRISTINE
To: AVENTIS PHARMA S.A.
Reel/Frame 011593/0095 →
Assignment of Assignor's Interest
Mar 21, 2001
From: TOUTAIN, HERVE; GUFFROY, MAGALI
To: AVENTIS PHARMA S.A.
Reel/Frame 011610/0401 →
Assignment of Assignor's Interest
Mar 30, 2001
From: BISSERY, MARIE-CHRISTINE
To: AVENTIS PHARMA S.A.
Reel/Frame 011644/0901 →
Assignment of Assignor's Interest
May 16, 2001
From: BISSERY, MARIE-CHRISTINE
To: AVENTIS PHARMA S.A.
Reel/Frame 011804/0558 →
Assignment of Assignor's Interest
Sep 14, 2001
From: LEUE, STEFANIE; GARCON, STEPHANIE; GREENE, ANDREW-ELLIOT; GENISSON, YVES
To: AVENTIS PHARMA S.A.
Reel/Frame 012170/0418 →
Assignment of Assignor's Interest
Dec 21, 2001
From: BISSERY, MARIE-CHRISTINE
To: AVENTIS PHARMA, S.A.
Reel/Frame 012396/0648 →
Assignment of Assignor's Interest
Apr 4, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016425/0173 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016470/0328 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016446/0212 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016446/0222 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016446/0231 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016446/0240 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016446/0246 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016447/0340 →
Assignment of Assignor's Interest
Apr 11, 2005
From: PHARMA, AVENTIS S.A.
To: PFIZER, INC.
Reel/Frame 016470/0309 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016470/0319 →
Assignment of Assignor's Interest
Apr 11, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016470/0342 →
Assignment of Assignor's Interest
Jun 9, 2005
From: AVENTIS PHARMA S.A.
To: PFIZER, INC.
Reel/Frame 016676/0354 →
Assignment of Assignor's Interest
Feb 21, 2007
From: AVENTIS PHARMA S.A.
To: PFIZER ENTERPRISES SARL
Reel/Frame 018915/0183 →
Assignee Address Correction
Nov 2, 2016
From: AVENTIS PHARMA S.A.
To: PFIZER INC.
Reel/Frame 040543/0797 →
Corrective Assignment to Correct the the Assignment Was Recorded in Error Previously Recorded on Reel 018915 Frame 0183. Assignor(S) Hereby Confirms the Original Assignment.
Nov 2, 2016
From: AVENTIS PHARMA S.A.
To: PFIZER INC.
Reel/Frame 040543/0840 →